<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00893178</url>
  </required_header>
  <id_info>
    <org_study_id>SMW 03</org_study_id>
    <nct_id>NCT00893178</nct_id>
  </id_info>
  <brief_title>Impact of Polymorphism on Pulmonary Pressure in Subjects With Pulmonary Hypertension of Different Cause</brief_title>
  <official_title>Impact of Different Genetic Polymorphism on the Pulmonary Pressure in Patients With Pulmonary Hypertension of Different Cause With Special Focus on Patients With Chronic Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heartcenter Leipzig GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulmonary Hypertension (PH) is a disease that is characterized by vasoconstriction of small
      vessels of the lung. Many cases do have proliferation of endothelial cells within these
      vessels. A possible influence of polymorphisms of genes relevant for inflammatory and
      endothelial processes is suspected.

      Especially patients with chronic heart failure can develope PH. The reasons therefore are
      lacking.

      The researchers investigate different polymorphism and the influence of these on pulmonary
      artery pressure (measured invasively) in patients with congestive heart failure (CHF) and
      patients with primary pulmonary hypertension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study consists of 3 arms-patients with CHF and PH, patients with CHF without PH and
      patients without CHF and PH.

      The PH measurement is due to routine catheterization, thereafter we measure different
      vasoactive polymorphism.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2007</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of the Expression of Glu 298ASP Polymorphism with pulmonary pressure</measure>
    <time_frame>Dec. 2010</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of G308A TNF alpha polymorphism within the different groups</measure>
    <time_frame>Dec. 2010</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Congestive Heart Failure</condition>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>CHF with elevated PAP</arm_group_label>
    <description>CHF patients (LVEF &gt; 35%) with elevated mean pulmonary pressure( &gt; 20 mmHg ) measured by pa catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHF patient without elevated PAP</arm_group_label>
    <description>CHF patients (LVEF &gt; 35%) with normal mean pulmonary pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal EF with elevated PAP</arm_group_label>
    <description>Patients with normal LVEF &lt; 60% with elevated mean pulmonary pressure</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      EDTA Blood, Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        CHF elevated pulmonary hypertension
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CHF with or without pulmonary hypertension or

          -  patients with normal LVEF and pulmonary hypertension

          -  right heart catheterization due to routine

          -  informed consent

        Exclusion Criteria:

          -  no right heart catheterization

          -  no informed consent

          -  elevated pulmonary pressure due to valve diseases or congenital heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sven Möbius-Winkler, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Leipzig-Heart Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart Center Leipzig- University Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2009</study_first_submitted>
  <study_first_submitted_qc>May 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2009</study_first_posted>
  <last_update_submitted>March 14, 2017</last_update_submitted>
  <last_update_submitted_qc>March 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Sven Möbius-Winkler</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>eNOS Polymorphism</keyword>
  <keyword>TNF alpha polymorphism</keyword>
  <keyword>pulmonary pressure</keyword>
  <keyword>polymorphism of vasoactive substances</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

